- Home
- ZENV vs XTNT Comparison
ZENV vs XTNT Comparison
Compare ZENV & XTNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZENV
- XTNT
- Stock Information
- Founded
- ZENV 2005
- XTNT N/A
- Country
- ZENV Brazil
- XTNT United States
- Employees
- ZENV N/A
- XTNT N/A
- Industry
- ZENV Computer Software: Prepackaged Software
- XTNT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ZENV Technology
- XTNT Health Care
- Exchange
- ZENV Nasdaq
- XTNT Nasdaq
- Market Cap
- ZENV 63.3M
- XTNT 55.6M
- IPO Year
- ZENV 2021
- XTNT N/A
- Fundamental
- Price
- ZENV $1.62
- XTNT $0.38
- Analyst Decision
- ZENV
- XTNT Strong Buy
- Analyst Count
- ZENV 0
- XTNT 1
- Target Price
- ZENV N/A
- XTNT $3.00
- AVG Volume (30 Days)
- ZENV 73.5K
- XTNT 224.7K
- Earning Date
- ZENV 11-18-2024
- XTNT 11-12-2024
- Dividend Yield
- ZENV N/A
- XTNT N/A
- EPS Growth
- ZENV N/A
- XTNT N/A
- EPS
- ZENV N/A
- XTNT N/A
- Revenue
- ZENV $173,594,726.00
- XTNT $113,862,000.00
- Revenue This Year
- ZENV $25.56
- XTNT $31.82
- Revenue Next Year
- ZENV $6.02
- XTNT $13.64
- P/E Ratio
- ZENV N/A
- XTNT N/A
- Revenue Growth
- ZENV 23.49
- XTNT 45.11
- 52 Week Low
- ZENV $1.00
- XTNT $0.33
- 52 Week High
- ZENV $3.88
- XTNT $1.31
- Technical
- Relative Strength Index (RSI)
- ZENV 54.93
- XTNT 35.87
- Support Level
- ZENV $1.61
- XTNT $0.35
- Resistance Level
- ZENV $1.78
- XTNT $0.39
- Average True Range (ATR)
- ZENV 0.12
- XTNT 0.02
- MACD
- ZENV -0.00
- XTNT 0.00
- Stochastic Oscillator
- ZENV 48.48
- XTNT 56.22
About ZENV Zenvia Inc.
Zenvia Inc provides a platform that enables companies to create unique journeys for their end customers across a variety of channels. The company operates in two reportable segments namely CPaaS and SaaS. It has a geographic presence in Brazil, the USA, Argentina, Mexico, and Others. The company generates the majority of its revenue from Brazil.
About XTNT Xtant Medical Holdings Inc.
Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the US.